Laboratory Diagnosis of Visceral Leishmaniasis
نویسندگان
چکیده
The group of diseases known as the leishmaniases are caused by obligate intracellular protozoa of the genus Leishmania (39). Natural transmission of leishmania is carried out by a certain species of sandfly of the genus Phlebotomus (Old World) or Lutzomyia (New World). These are present in three different forms: (i) visceral leishmaniasis (VL), (ii) cutaneous leishmaniasis, and (iii) mucocutaneous leishmaniasis. The visceral form, also known as black sickness or kala-azar in Asia, is characterized by prolonged fever, splenomegaly, hepatomegaly, substantial weight loss, progressive anemia, pancytopenia, and hypergammaglobulinemia and is complicated by serious infections. It is the most severe form of the disease and, left untreated, is usually fatal. Although confirmed cases of VL have been reported from 66 countries, 90% of the world’s VL burden occurs on the Indian subcontinent and in Sudan (12, 21, 65, 80). After recovery, some patients (50% in Sudan and 1 to 3% in India) develop post-kala-azar dermal leishmaniasis (PKDL), which requires prolonged and expensive treatment (57, 83). PKDL patients also play an important role in VL transmission (77). VL is typically caused by the Leishmania donovani complex, which includes three species: L. donovani, Leishmania infantum, and Leishmania chagasi. The clinical features of VL caused by different species are different, and each parasite has a unique epidemiological pattern. On the Indian subcontinent, the disease is almost exclusively caused by L. donovani. The initial report of Leishmania tropica causing VL in India (61) was refuted by us and others (74, 78). L. infantum is responsible for VL in children in the Mediterranean basin. However, due to increasing prevalence of human immunodeficiency virus (HIV) infection in this region, HIV-VL coinfection in the adult population is being reported frequently. L. chagasi causes VL in children in Latin America, where lymphadenopathy is a dominant clinical feature. L. tropica, the causative organism of Old World cutaneous leishmaniasis, is reported to produce visceral disease in nonimmune persons (41). Similarly, visceralization by Leishmania amazonensis, has also been reported (28). Clinical manifestations of all forms of VL change from time to time, and this is the case more so in AIDS patients (8, 21, 42, 43, 48).
منابع مشابه
An Overview of theLaboratory Diagnostic Procedures of Visceral Leishmaniasis (Kala-Azar)
Abstract Visceral leishmaniasis (Kala-azar) is a systemic infection disease that can be diagnosed by some invasive procedures such as splenic, liver biopsy or bone marrow aspiration, whichare determined as the gold standards for diagnosing of this disease. At present, a variety of noninvasive tests having different specificities and sensitivities are available for the diagnosis of visceral ...
متن کاملVisceral leishmaniasis in children
Background and Objectives: Visceral leishmaniasis is a chronic disease in Africa and Asia, children under 5 years are affecting with L.infantum and older children and young adult with L.donovani Purpose of this study describes the characteristics of epidemiologic and clinicopathophysiologic and response to treatment of patient that affected in East Azarbaijan compared with other endemic areas ...
متن کاملEvaluation of DAT in the Diagnosis of Visceral Leishmaniasis in Children Hospitals in Tabriz from 1992 to 1996
Since the bone marrow puncture and its study is a time-consuming and costly process and in addition, the direct agglutination test has a high sensitivity and is easier and quicker to perform for the diagnosis of Kala-azar, and considering the less value of bone marrow puncture for the definite diagnosis of endemic hepatosplenomegaly in Meshkinshahr, this study was performed to determine the dia...
متن کاملImportance of L. Infantum H2B Recombinant Antigen for Serodiagnosis of Visceral Leishmaniasis
Background: Visceral leishmaniasis (VL) can lead to death in more than 95% of cases if left untreated. Accurate and early diagnosis has an important role in reducing mortality rate of this disease. Objective: To express recombinant H2B antigen from an Iranian isolate of Leishmania Infantum and evaluate its efficacy in the diagnosis of VL. Metho...
متن کاملA Capture ELISA for the Diagnosis of Visceral Leishmaniasis Using a Monoclonal Antibody against a Leishmanial
capture ELISA system was developed for diagnosis of visceral leishmaniasis (VL) using a monoclonal antibody raised against an antigen previously detected in the urine of VL patients. Urine samples from confirmed VL cases from Yemen, Nepal, Spain, Sudan and Brazil were tested in the capture ELISA in comparison with urine samples from endemic and non-endemic areas along with urine samples from pa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2002